Results 191 to 200 of about 5,691,277 (301)

A decade of cannabis‐related hospital admissions in Victoria, Australia: A retrospective observational study

Addiction, EarlyView.
Abstract Background and aims Over the past decade, there has been increased lifetime use of illicit and medical cannabis, underscoring the need to examine public health impacts. This includes reports of increased cannabis‐related psychosis. In this context, this study aimed to determine all cannabis‐related hospital admissions in Victoria, Australia ...
Myfanwy Graham, Janneke Berecki‐Gisolf, Jane Hayman, Adrian Carter, Shalini Arunogiri, Suzanne Nielsen   +5 more
wiley   +1 more source

Pharmacovigilance in medical cannabis therapy among physicians in Poland: pharmacovigilance knowledge, ADR reporting practice and cannabis-related safety reporting. [PDF]

Front Public Health
Kopciuch D, Kapcińska A, Kus K, Russo E.   +3 more
europepmc   +1 more source

Accidental overdose admissions and premature death: A large population‐based data‐linkage cohort study in New South Wales, Australia (PAVLOVA 4)

Addiction, EarlyView.
Abstract Background and aims People with substance use disorders have reduced life‐expectancy; however, risks of premature death from injuries and natural causes following an accidental overdose are not well characterised. This study aimed to estimate risk of premature death (by cause and over time), and disease burden following hospitalised accidental
Firouzeh Noghrehchi, Rose Cairns, Darren M. Roberts, Kirsten C. Morley, Paul S. Haber, Nicholas A. Buckley   +5 more
wiley   +1 more source

Adverse events associated with medical cannabis reported within a centralized call center. [PDF]

Front Pharmacol
Illamola SM, Lyu X, Luciana M, Dahmer S, Lehfeldt P, Dikmen S, Kaloustian I, Garretson M, Kingston RL, Leppik I, Sherwin CM, Birnbaum AK.   +11 more
europepmc   +1 more source

Issues spotlight: Medical cannabis [PDF]

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2018
openaire   +2 more sources

Problems in comparing tobacco regulatory models and excise when only two countries are considered

Addiction, EarlyView.
Simon Chapman, Sam Egger, Becky Freeman
wiley   +1 more source

Changes in the transition from cannabis use to use disorder by decade of first use: Findings from the Australian National Mental Health and Wellbeing surveys

Addiction, EarlyView.
Abstract Background and aims As cannabis becomes increasingly accessible and products more potent, it is critical that we understand how this may impact the risk of transitioning from cannabis use to cannabis use disorder (CUD). We aimed to examine whether the risk and speed of transition from cannabis use to CUD differ by decade of first cannabis use.
Jack Wilson, Siobhan O'Dean, Christina Marel, Olivia Dobson, Matthew Sunderland, Steph Kershaw, Tara Gückel, Emma Krogh Devine, Tim Slade, Maree Teesson, Emily Stockings   +10 more
wiley   +1 more source

Perceived Prescription Opioid and Medical Cannabis-Related Stigma Among US Adults With and Physicians Who Treat Chronic Pain. [PDF]

Drug Alcohol Rev
Gutkind S, McGinty EE, Stone EM, Tormohlen KN.   +3 more
europepmc   +1 more source

Substance‐free and substance‐related reinforcement in relation to substance use: A meta‐analysis

Addiction, EarlyView.
Abstract Background and aims Contemporary behavioral economic theory conceptualizes addiction as an operant reinforcer pathology in which substance use is substantively influenced by reinforcement obtained through substance‐free sources. The aim of the current meta‐analysis was to quantitatively synthesize cross‐sectional associations between both ...
Brian M. Bird, Molly L. Garber, Samuele F. Acuff, Keanan J. Joyner, James G. Murphy, James MacKillop   +5 more
wiley   +1 more source

Medical Cannabis and Opioid Receipt Among Adults With Chronic Pain. [PDF]

JAMA Intern Med
Slawek DE, Zhang C, Dahmer S, Sohler N, Zolotov Y, Starrels JL, Deng Y, Calderon DiFrancesca G, Levin FR, Ross J, Minami H, Cunningham CO, Arnsten JH.   +12 more
europepmc   +1 more source